Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA‐87 and LALA‐94 trials

Second malignant neoplasms are a serious complication after successful treatment of childhood acute lymphoblastic leukemia (ALL). Although treatment intensity and outcome were not comparable, with improvements in survival it is important to evaluate the rate and the type of second neoplasms in adults with ALL.

[1]  J. Estève,et al.  An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies , 2007, Statistics in medicine.

[2]  H. Kantarjian,et al.  Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia , 2004, Cancer.

[3]  H. Dombret,et al.  Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Cayuela,et al.  Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  L. Robison,et al.  Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. , 2002, Blood.

[6]  M. Tallman,et al.  Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993). , 2001 .

[7]  M. Schrappe,et al.  Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. , 2000, Blood.

[8]  M. Relling,et al.  High incidence of secondary brain tumours after radiotherapy and antimetabolites , 1999, The Lancet.

[9]  W. Rabitsch,et al.  Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD) , 1999, Bone Marrow Transplantation.

[10]  M. Hudson,et al.  Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Richards,et al.  Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA , 1997, British journal of haematology.

[12]  R. Hoover,et al.  Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.

[13]  L. Robison,et al.  Malignant neoplasms following bone marrow transplantation. , 1996, Blood.

[14]  M. Weinstock,et al.  Epidemiology of human papillomaviruses. , 1995, Dermatologic clinics.

[15]  A. Zauber,et al.  Incidence of second cancers in patients treated for Hodgkin's disease. , 1995, Journal of the National Cancer Institute.

[16]  R. Larson,et al.  A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. , 1995, Blood.

[17]  S. Wacholder,et al.  Second cancers among long-term survivors of non-Hodgkin's lymphoma. , 1993, Journal of the National Cancer Institute.

[18]  C. Gisselbrecht,et al.  Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  E. Thiel,et al.  Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group. , 1993, Leukemia.

[20]  N R Schneider,et al.  Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  F. Behm,et al.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. , 1991, The New England journal of medicine.

[22]  R. Nygaard,et al.  Second Malignant Neoplasms in Patients Treated for Childhood Leukemia: A Population‐based Cohort Study from the Nordic Countries , 1991, Acta paediatrica Scandinavica.

[23]  L. Robison,et al.  Second neoplasms after acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[24]  J. Whitlock,et al.  Epipodophyllotoxin‐related leukemia. Identification of a new subset of secondary leukemia , 1991, Cancer.

[25]  R. Hoover,et al.  Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. , 1991, Cancer research.

[26]  M. Minden,et al.  Cutaneous and mucosal neoplasms in bone marrow transplant recipients , 1990, Cancer.

[27]  F. Behm,et al.  Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. , 1989, The New England journal of medicine.

[28]  D M Green,et al.  Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1987, The New England journal of medicine.

[29]  S. Sallan,et al.  Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13‐year experience from the Dana‐Farber cancer institute and the children's hospital , 1987, Cancer.

[30]  O. Oberlin,et al.  Second malignant neoplasms in children: an update from the Late Effects Study Group. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.